Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects.

Studies of the possibility that thyroxine (T4) is converted to 3.5,3'-triiodo-L-thyronine (T3) in the extrathyroidal tissues in man have been conducted in 13 patients, all but two of whom were athyreotic or hypothyroid, and all of whom were receiving at least physiological replacement doses of synthetic sodium-L-thyroxine.T3 was found in the sera of all patients, in concentrations ranging between 243 and 680 ng/100 ml (normal range 170-270 ng/100 ml). These concentrations were far in excess of those which would have been expected on the basis of the T3 contamination of the administered T4, as measured by the same technique employed in the analysis of serum. When oral medication was enriched with (125)I-labeled T4 for 8 or more days, labeled T3 and tetraiodothyroacetic acid (Tetrac or TA(4)) were found in the serum to the extent of approximately 2-5% of total radioactivity, as assessed by unidimensional paper chromatography. The same results were obtained with a specially purified lot of radioactive T4 containing less than 0.1% T3 as a contaminant. The identities of the (125)I-labeled T3 and TA(4) were verified by two-dimensional chromatography as well as by specific patterns of binding in serum. The labeled T3 isolated was bound by albumin and by T4-binding globulin (TBG), but not by T4-binding prealbumin (TBPA): in contrast the labeled TA(4) was bound by albumin and TBPA, but not by TBG. To exclude the possibility that the conversion of T4 to T3 was a peculiarity of the oral route of administration, the sera of two additional patients were obtained 48 hr after 7-day courses of daily intravenous injections of a mixture of stable and (125)I-labeled T4. Both stable and labeled T3 were likewise found in these sera. In contrast to earlier experiments in humans in which (131)I-labeled T3 was not definitively demonstrated in serum after a single intravenous injection of (131)I-labeled T4, the present findings are taken to provide conclusive evidence of the extrathyroidal conversion of T4 to T3 in man. These results raise once again the question of the extent to which the metabolic effect of T4 is mediated through the peripheral generation of T3.

[1]  Hollander Cs On the nature of the circulating thyroid hormone: clinical studies of triiodothyronine and thyroxine in serum using gas chromatographic methods. , 1968 .

[2]  J. Prudden,et al.  THE METABOLISM OF I131-LABELED THYROXINE, TRIIODOTHYRONINE AND DIIODOTYROSINE BY ANISOLATED PERFUSED RABBIT LIVER1 , 1959 .

[3]  S. Ingbar Observations concerning the binding of thyroid hormones by human serum prealbumin. , 1963, The Journal of clinical investigation.

[4]  W. Trotter,et al.  Effect of 3:5:3'-L-triiodothyronine in myxoedema. , 1952, Lancet.

[5]  J. Wiswell,et al.  Disappearance of I-131-triiodo-thyronine from the plasma in the presence of fever. , 1962, The Journal of clinical endocrinology and metabolism.

[6]  H. Lardy,et al.  Enzymatic conversion of thyroxine and triiodothyronine to the corresponding acetic acid analogues. , 1956, Endocrinology.

[7]  J. Stanbury,et al.  The in vivo conversion of thyroxine to 3:5:3'triiodothyronine. , 1958, The Journal of clinical endocrinology and metabolism.

[8]  K. Sterling,et al.  Determination of triiodothyronine concentration in human serum. , 1969, The Journal of clinical investigation.

[9]  J. Mirouze,et al.  [New technic for the study of the metabolism of thyroid hormones (T4-125-T3-131). Experimental and clinical data]. , 1967, Annales d'Endocrinologie.

[10]  K. Inoue,et al.  Quantitative studies on the iodinated components secreted by the rat thyroid gland as determined by in situ perfusion. , 1967, Endocrinology.

[11]  B. Murphy,et al.  DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING. , 1964, The Journal of clinical endocrinology and metabolism.

[12]  J. Gross,et al.  The identification of 3:5:3'-L-triiodothyronine in human plasma. , 1952, Lancet.

[13]  G. I. Gleason Some notes on the exchange of iodine with thyroxine homologues. , 1955, The Journal of biological chemistry.

[14]  K. Sterling,et al.  Thyroxine transport in thyrotoxicosis and hypothyroidism. , 1967, The Journal of clinical investigation.

[15]  K. Sterling,et al.  Disappearance from serum of I131-labeled l-thyroxine and l-triiodothyronine in euthyroid subjects. , 1954, The Journal of clinical investigation.

[16]  F. Larson,et al.  Metabolism of L-thyroxine by human tissue slices. , 1959, The Journal of clinical investigation.

[17]  N. Freinkel,et al.  Simultaneous estimation of rates of thyroxine degradation and thyroid hormone synthesis. , 1955, The Journal of clinical investigation.

[18]  S. Ingbar,et al.  The peripheral metabolism of tri- and tetraiodothyroacetic acids in man. , 1961, The Journal of clinical endocrinology and metabolism.

[19]  C. P. Leblond,et al.  Metabolites of Thyroxine.∗ , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[20]  D. Fisher,et al.  WHOLE-BODY COUNTING OF 131-I-LABELED TRIIODOTHYRONINE. , 1964, The Journal of clinical endocrinology and metabolism.

[21]  F. Larson,et al.  In vitro Conversion of Thyroxin to Triiodothyronine by Kidney Slices.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[22]  A. Taurog,et al.  TSH-induced thyroxine release from puromycin-blocked thyroid glands of intact rabbits. , 1966, Endocrinology.

[23]  J. Lerman THE PHYSIOLOGIC ACTIVITY OF Z-TRIIODOTHYRONINE* , 1953 .

[24]  K. Sterling,et al.  Radiothyroxine turnover studies in myxedema, thyrotoxicosis, and hypermetabolism without endocrine disease. , 1956, Journal of Clinical Investigation.

[25]  S. Ingbar,et al.  The influence of reserpine, serotonin and metabolites of tryptophane on the degradation of thyroxine and its derivatives. , 1961, Endocrinology.

[26]  K. Sterling Radiothyroxine turnover studies in thyroid disease after therapy. , 1958, The Journal of clinical investigation.

[27]  R. I. Gregerman,et al.  Acceleration of thyroxine and triiodothyronine turnover during bacterial pulmonary infections and fever: implications for the functional state of the thyroid during stress and in senescence. , 1967, The Journal of clinical endocrinology and metabolism.

[28]  K. Woeber,et al.  The effects of an acute load of thyroxine on the transport and peripheral metabolism of triiodothyronine in man. , 1970, The Journal of clinical investigation.

[29]  V. Galton,et al.  The identification of the acetic acid analogues of thyroxine and tri-iodothyronine in mammalian tissues. , 1959, The Biochemical journal.

[30]  K. Woeber,et al.  The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. , 1970, Journal of Clinical Investigation.

[31]  R. Michel,et al.  Sur la nature des combinaisons iodées excrétées par le foie et le rein après administration de L-thyroxine et de L-3:5:3′-triiodothyronine , 1954 .

[32]  J. Stanbury,et al.  Conversion of thyroxine to 3-5-3'-triiodothyronine in vivo. , 1955, The Journal of clinical endocrinology and metabolism.

[33]  K. Woeber,et al.  OBSERVATIONS CONCERNING THE THYROXINE-BINDING SITE OF PREALBUMIN IN HUMAN SERUM. , 1964, Endocrinology.